Results 221 to 230 of about 332,806 (355)

Phenotype characterization of heart failure with preserved ejection fraction in medical device and surgical trials

open access: yesESC Heart Failure, EarlyView.
This systematic review identified 24 clinical trials of medical device and surgical interventions for HFpEF, with 16 demonstrating at least safety and feasibility, but little evidence of long‐term benefit. Phenotype‐based responses suggest that certain interventions may benefit specific HFpEF subgroups, yet most trials suffered from heterogeneous ...
Kurdo Araz   +5 more
wiley   +1 more source

Student Aboriginal health worker smoking: findings from a training college in Western Australia

open access: yesAustralian and New Zealand Journal of Public Health, 2012
Veronica Hoad, Cheryl Hayward
doaj   +1 more source

Non-urgent emergency department visits by patients from a resident ambulatory care clinic

open access: bronze, 1995
Peter J. McLeod   +4 more
openalex   +1 more source

Ambulatory Care of the Osteoarthritis

open access: yesJournal of the Korean Medical Association, 2000
Eun Kyu Song, Seong Tae Cho
openaire   +2 more sources

A novel treatment score (QUAD score) to promote treatment optimization in heart failure with a reduced ejection fraction

open access: yesESC Heart Failure, EarlyView.
The QUAD score was developed to promote adherence to clinical practice guidelines for patients with heart failure and a reduced left ventricular ejection fraction <50%. In newly diagnosed patients who had completed therapy titration, we found that patients with an excellent QUAD score had a significant reduction in the risk of mortality or ...
Henry Oluwasefunmi Savage   +23 more
wiley   +1 more source

Improving adverse-drug-reaction reporting in ambulatory care clinics at a Veterans Affairs hospital [PDF]

open access: bronze, 2002
Monica B. Aspinall   +4 more
openalex   +1 more source

SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI

open access: yesESC Heart Failure, EarlyView.
Abstract In the 2021 European Society of Cardiology (ESC) heart failure (HF) guidelines, sodium–glucose cotransporter 2 (SGLT2) inhibitors were recommended for the prevention of HF in patients with type 2 diabetes mellitus (T2DM) and for the treatment of HF with reduced ejection fraction (HFrEF).
Marco Metra   +25 more
wiley   +1 more source

Home - About - Disclaimer - Privacy